Citation Impact
Citing Papers
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
1978
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
2009 StandoutScience
Investigation of relation between use of oral contraceptives and thromboembolic disease.
1968
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 Standout
Mercury, Fish Oils, and the Risk of Myocardial Infarction
2002
Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure
1998
Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome
2003 StandoutNature
Unstable angina: Pathogenesis, diagnosis, and treatment
1993
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
1997 Standout
Neuroendocrine changes in acute myocardial infarction
1988
HOW DO FISH OILS AFFECT VASCULAR FUNCTION?
1995
Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study
2001
Should there be a moratorium on the use of cholesterol lowering drugs?
1992
The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70
1997 StandoutNobel
Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion
2009
Effect of an increased intake of α-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study
2002
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Coronary heart disease: seven dietary factors
1991 Standout
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Decreased Cardiolipin Synthesis Corresponds with Cytochromec Release in Palmitate-induced Cardiomyocyte Apoptosis
2001
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
Dietary fatty acids in human thrombosis and hemostasis
1997
PPARδ Activation Normalizes Cardiac Substrate Metabolism and Reduces Right Ventricular Hypertrophy in Congestive Heart Failure
2007
Meat Intake and Mortality
2009
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease
1988
Dietary Intake of Marine n-3 Fatty Acids, Fish Intake, and the Risk of Coronary Disease among Men
1995
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Fish Consumption and the 30-Year Risk of Fatal Myocardial Infarction
1997
Risk factors for acute myocardial infarction in Indians: a case-control study
1996
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina
2004
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
2003
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
The malonyl CoA axis as a potential target for treating ischaemic heart disease
2008
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Menopause and Risk Factors for Coronary Heart Disease
1989
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1995 Standout
Glucose-Insulin-Potassium Therapy for Treatment of Acute Myocardial Infarction
1997
ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase
1979 StandoutNatureNobel
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.
1987 Standout
Does fish oil lower blood pressure? A meta-analysis of controlled trials.
1993
The Hutchinson-Gilford progeria syndrome
1972
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
1992 StandoutNobel
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
1994 Standout
Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation
2004
Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart
1972
Suppression of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity and Inhibition of Growth of Human Fibroblasts by 7-Ketocholesterol
1974 StandoutNobel
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man.
1978
The Chemical Form of Mercury in Fish
2003 StandoutScience
Premenopausal castration and documented coronary atherosclerosis
1971
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Controversies in meta-analysis: the case of the trials of serum cholesterol reduction
1993
Evaluating the federal role in financing health-related research
1996 StandoutNobel
Comparison of the effects of some C27−, C21−, and C19-steroids upon hepatic sterol synthesis and hydroxymethylglutaryl—CoA reductase activity
1970
Atherogenesis: a postprandial phenomenon.
1979 Standout
Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction
1979
High density lipoprotein as a protective factor against coronary heart disease
1977 Standout
RELATION BETWEEN PLASMA FREE FATTY ACIDS AND ARRHYTHMIAS WITHIN THE FIRST TWELVE HOURS OF ACUTE MYOCARDIAL INFARCTION
1983
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Total Synthesis of α-Pyrone Meroterpenoids, Novel Bioactive Microbial Metabolites
2005 StandoutNobel
INFANT MORTALITY, CHILDHOOD NUTRITION, AND ISCHAEMIC HEART DISEASE IN ENGLAND AND WALES
1986 Standout
Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation
1993
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Dietary Fats and Blood Pressure
1994
Age trend of mortality from coronary artery disease in women and observations on the reproductive patterns of those affected
1964
Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.
1988
Increases in serum unbound free fatty acid levels following coronary angioplasty
1996
Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction
1981
Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart
1981
Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women.
1994
Omega-3 Fatty Acids in Adipose Tissue and Risk of Myocardial Infarction
1999
Complete protein sequence and identification of structural domains of human apolipoprotein B
1986 Nature
Plasma Catecholamines and Carbohydrate Metabolism in Patients with Acute Myocardial Infarction
1974
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
1994
Myocardial infarction in young women
1976
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
1996 StandoutNobel
Estrogen and Coronary Heart Disease in Women
1991 Standout
Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction
1975
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Meat consumption, health, and the environment
2018 StandoutScience
ORAL-CONTRACEPTIVE USE IN RELATION TO MYOCARDIAL INFARCTION
1979
SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
1986
Sudden cardiac death: the lost fatty acid hypothesis
2006
Malonyl CoA Control of Fatty Acid Oxidation in the Ischemic Heart
2002
MYOCARDIAL INFARCTION IN WOMEN
1955
Influence of free fatty acids on myocardial oxygen consumption and ischemic injury
1981
Myocardial Infarction and Estrogen Therapy in Post-Menopausal Women
1976
LIGNOCAINE PROPHYLAXIS IN ACUTE MYOCARDIAL INFARCTION: AN EVALUATION OF RANDOMISED TRIALS
1981
Influence of sex and sex hormones upon the development of atherosclerosis and upon the lipoproteins of plasma
1955
Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart
1980
Metabolic fate of extracted glucose in normal human myocardium.
1985
ORAL CONTRACEPTIVE USE IN RELATION TO NONFATAL MYOCARDIAL INFARCTION
1980
NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT
1965 Nature
Observations on the change in shape of blood platelets brought about by adenosine diphosphate
1970
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
2002 Standout
Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis
1967
Estrogen use and myocardial infarction risk: A case-control study
1984
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
MYOCARDIAL ISCHÆMIA, RISK FACTORS AND DEATH FROM CORONARY HEART-DISEASE
1977
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 StandoutScience
On some Late Effects of Bilateral Oophorectomy in the Age Range 15–30 Years
1975
Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1998
Menopause and the Risk of Coronary Heart Disease in Women
1987
ADP Receptors on Platelets
1996
Uses of coronary heart attack registers.
1978
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Inhibitory effects of the D(−) isomer of 3-hydroxybutyrate on cardiac non-esterified fatty acid uptake and oxygen demand induced by norepinephrine in the intact dog
1985
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
2003 Standout
Gonadal Function and the Development of Coronary Heart Disease
1963
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Meta-analysis in clinical trials
1986 Standout
Menopause and Risk of Cardiovascular Disease
1976 Standout
Ischaemic Heart Disease in Young Women
1974
Works of M.F. Oliver being referenced
Oral Contraceptives and Myocardial Infarction
1973
Effects of Maxepa on serum lipids in hypercholesterolaemic subjects
1989
Might treatment of hypercholesterolaemia increase non-cardiac mortality?
1991
Dietary fat and coronary heart disease.
1987
Adipose Tissue Fatty Acids and Blood Pressure in Middle-Aged Men from Southern Italy
1987
INITIAL METABOLIC AND HORMONAL RESPONSE TO ACUTE MYOCARDIAL INFARCTION
1974
Relationship of Epicardial ST Segment Elevation to the Plasma Free Fatty Acid/Albumin Ratio during Coronary Occlusion in Dogs
1976
SERUM CHOLESTEROL-THE KNAVE OF HEARTS AND THE JOKER
1981
SERUM LIPOPROTEIN PATTERNS IN CORONARY SCLEROSIS AND ASSOCIATED CONDITIONS
1955
THROMBOSIS AND ŒSTROGENS
1967
The Role of Free Fatty Acids in the Production of Ventricular Arrhythmias after Acute Coronary Artery Occlusion
1971
Metabolic Response during Impending Myocardial Infarction
1972
Regional variations in mortality from ischaemic heart and cerebrovascular disease in Britain.
1978
Turnover of Plasma Glucose and Free Fatty Acids in Patients on the First Day after Myocardial Infarction
1976
SERUM-FREE-FATTY-ACIDS AFTER ACUTE MYOCARDIAL INFARCTION AND CEREBRAL VASCULAR OCCLUSION
1966
ENDOCRINE ASPECTS OF CORONARY SCLEROSIS
1956
Prognosis of new and worsening angina pectoris.
1976
Benefits and Risks of Drugs in Secondary Prevention of Ischaemic Heart Diseasc--a Summary
1986
FREE FATTY ACIDS, HEPARIN, AND ARRHYTHMIAS DURING EXPERIMENTAL MYOCARDIAL INFARCTION
1969
Myocardial infarction in young men. Study of risk factors in nine countries.
1975
CLOFIBRATE AND GALLSTONES
1975
Prevention of coronary heart disease--propaganda, promises, problems, and prospects.
1986
Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials.
1991
LINOLEIC AND EICOSAPENTAENOIC ACIDS IN ADIPOSE TISSUE AND PLATELETS AND RISK OF CORONARY HEART DISEASE
1987
The effect of estrogens on the plasma lipids in coronary artery disease
1954
Effects of p-chlorophenoxyisobutyrate on myocardial free fatty acid extraction, ventricular blood flow, and epicardial ST-segment elevation during coronary occlusion in dogs.
1976
The Effect of Antilipolytic Agents on Cyclic AMP, Free Fatty Acid and Total Catecholamine Concentrations in Plasma
1976
Free fatty acids during acute myocardial infarction
1971
EFFECT OF BILATERAL OVARIECTOMY ON CORONARY-ARTERY DISEASE AND SERUM-LIPID LEVELS
1959
NATURAL HISTORY OF UNSTABLE ANGINA
1972
The initial changes in platelet morphology following the addition of adenosine diphosphate
1965
Natural history of acute coronary heart attacks. A community study.
1972
CONTROL OF VENTRICULAR ARRHYTHMIAS DURING MYOCARDIAL INFARCTION BY ANTILIPOLYTIC TREATMENT USING A NICOTINIC-ACID ANALOGUE
1975
Influence ofn-6versusn-3Polyunsaturated Fatty Acids in Diets Low in Saturated Fatty Acids on Plasma Lipoproteins and Hemostatic Factors
1997
Antilipolytic therapy in angina pectoris. Reduction of exercise-induced ST segment depression.
1976
Progeria and Atherosclerosis
1955
Hormones and Atherosclerosis
1958
Further observations on the effects of atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levels
1963
Linoleic acid content in adipose tissue and coronary heart disease.
1986
The Influence of the Sex Hormones on the Circulating Lipids and Lipoproteins in Coronary Sclerosis
1956
VENTRICULAR FIBRILLATION COMPLICATING ACUTE MYOCARDIAL INFARCTION
1968